Dr. François Bénard trained in medicine and nuclear medicine in Sherbrooke, Canada. After undertaking a Research Fellowship in Positron Emission Tomography at the University of Pennsylvania, he returned to Sherbrooke, where he was chief of the molecular imaging centre at the Centre Hospitalier Universitaire de Sherbrooke, and Professor of nuclear medicine and radiobiology at the Université de Sherbrooke.
Dr. Bénard is currently the BC Leadership Chair in Functional Cancer Imaging, based at the University of British Columbia (UBC), and Professor in the department of Radiology. Dr. Bénard is also the Vice President, Research and Distinguished Scientist at BC Cancer, and the recipient of the 2015 NSERC Brockhouse Canada Prize for Interdisciplinary Research in Science and Engineering. His interests combine state‐of‐the art clinical care with a thriving translational research program in imaging and radionuclide therapy. His research focuses on the development of novel radiopharmaceuticals for cancer diagnosis and therapy, and the development of non-invasive methods to predict and monitor the response of primary and metastatic tumours to chemotherapy.
Dr. Bénard's research interest lies in the development of novel radiopharmaceuticals for diagnosis and targeted radionuclide therapy of various cancer types, as well as cyclotron production of isotopes. The identification of new targets, the design of potent targeting vector and the access to adequate radioisotopes are the key to develop efficient radiopharmaceuticals.
University of British Columbia, Department of Radiology
Vice President Research, BC Cancer, part of the Provincial Health Services Authority
Associate Dean, University of British Columbia
Distinguished Scientist, BC Cancer Research Center
BC Leadership Chair in Functional Cancer Imaging, Department of Radiology, University of British Columbia
Professor, Department of Radiology, University of British Columbia